Proceedings of the National Academy of Sciences of the United States of America
-
Proc. Natl. Acad. Sci. U.S.A. · Dec 2007
Ecological feedbacks following deforestation create the potential for a catastrophic ecosystem shift in tropical dry forest.
The long-term ecological response to recurrent deforestation associated with shifting cultivation remains poorly investigated, especially in the dry tropics. We present a study of phosphorus (P) dynamics in the southern Yucatán, highlighting the possibility of abrupt shifts in biogeochemical cycling resulting from positive feedbacks between vegetation and its limiting resources. After three cultivation-fallow cycles, available soil P declines by 44%, and one-time P inputs from biomass burning decline by 76% from mature forest levels. ⋯ Degradation induced by hydrological and biogeochemical feedbacks on P cycling under shifting cultivation will affect farmers in the near future. Without financial support to encourage the use of fertilizer, farmers could increase the fallow period, clear new land, or abandon agriculture for off-farm employment. Their response will determine the regional balance between forest loss and forest regrowth, as well as the frequency of use and rate of recovery at a local scale, further feeding back on ecological processes at multiple scales.
-
Proc. Natl. Acad. Sci. U.S.A. · Dec 2007
Hemopressin is an inverse agonist of CB1 cannabinoid receptors.
To date, the endogenous ligands described for cannabinoid receptors have been derived from membrane lipids. To identify a peptide ligand for CB(1) cannabinoid receptors, we used the recently described conformation-state sensitive antibodies and screened a panel of endogenous peptides from rodent brain or adipose tissue. This led to the identification of hemopressin (PVNFKFLSH) as a peptide ligand that selectively binds CB(1) cannabinoid receptors. ⋯ Finally, we examine the activity of hemopressin in vivo using different models of pain and find that it exhibits antinociceptive effects when administered by either intrathecal, intraplantar, or oral routes, underscoring hemopressin's therapeutic potential. These results represent a demonstration of a peptide ligand for CB(1) cannabinoid receptors that also exhibits analgesic properties. These findings are likely to have a profound impact on the development of novel therapeutics targeting CB(1) receptors.